Apple Faces Potential US Import Ban on Watches Due to Patent Violation Ruled by ITC

Biden administration has 60 days to veto decision; ban would affect Apple Watch models with light-based pulse oximetry after patent violation ruled by International Trade Commission.

The US International Trade Commission (ITC) has declared that Apple violated patents held by medical technology company Masimo with its Apple watch, leading to a potential import ban.
The debated technology, a light-based pulse oximetry function for measuring blood oxygen levels, first appeared in the Apple Watch Series 6 and has been featured in all Series and Ultra models since.
The ITC's ban decision still faces a 60-day presidential review period during which President Biden can veto the ruling; previous presidents have rarely overruled such decisions.
Should the ITC's order take effect, Apple watches with the contested technology could no longer be imported into the US or produced domestically without licensing the relevant technology from Masimo.
This is not the first time Apple has faced charges of patent infringement; earlier this year, the Biden administration did not veto an ITC order finding Apple guilty of violating patents held by AliveCor.